Ralliant Corporation (NYSE:RAL) Short Interest Update

Ralliant Corporation (NYSE:RAL) was the recipient of a large growth in short interest in February. As of February 13th, there was short interest totaling 4,566,002 shares, a growth of 21.8% from the January 29th total of 3,747,948 shares. Approximately 4.0% of the company’s stock are short sold. Based on an average trading volume of 3,777,582 shares, the short-interest ratio is currently 1.2 days. Based on an average trading volume of 3,777,582 shares, the short-interest ratio is currently 1.2 days. Approximately 4.0% of the company’s stock are short sold.

Ralliant Stock Performance

Shares of Ralliant stock opened at $46.36 on Friday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.58 and a current ratio of 0.84. Ralliant has a 1 year low of $37.27 and a 1 year high of $57.02. The firm’s 50-day simple moving average is $49.08 and its 200-day simple moving average is $46.63. The firm has a market cap of $5.18 billion and a PE ratio of 23.65.

Ralliant (NYSE:RAL) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.02. The firm had revenue of $554.60 million during the quarter, compared to the consensus estimate of $543.04 million. Ralliant’s quarterly revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Monday, March 9th. Ralliant’s payout ratio is 10.20%.

Analyst Ratings Changes

RAL has been the topic of a number of recent analyst reports. Oppenheimer cut their price objective on shares of Ralliant from $60.00 to $50.00 and set an “outperform” rating on the stock in a report on Friday, February 6th. Barclays dropped their target price on Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a research report on Monday, February 9th. Zacks Research cut Ralliant from a “hold” rating to a “strong sell” rating in a research note on Monday, February 9th. Truist Financial reduced their price target on Ralliant from $62.00 to $49.00 and set a “buy” rating for the company in a report on Friday, February 6th. Finally, Weiss Ratings downgraded Ralliant from a “hold (c)” rating to a “sell (d)” rating in a report on Thursday, February 5th. Seven investment analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Ralliant currently has an average rating of “Hold” and an average price target of $50.50.

Insider Activity

In other news, Director Kevin E. Bryant bought 1,250 shares of Ralliant stock in a transaction dated Friday, February 6th. The shares were acquired at an average cost of $39.97 per share, with a total value of $49,962.50. Following the completion of the transaction, the director owned 4,653 shares in the company, valued at approximately $185,980.41. This trade represents a 36.73% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kate Mitchell bought 2,350 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The stock was purchased at an average price of $42.48 per share, with a total value of $99,828.00. Following the completion of the purchase, the director directly owned 8,411 shares of the company’s stock, valued at approximately $357,299.28. This trade represents a 38.77% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 8,145 shares of company stock worth $332,233 in the last ninety days.

Hedge Funds Weigh In On Ralliant

A number of hedge funds have recently added to or reduced their stakes in RAL. Danske Bank A S acquired a new stake in shares of Ralliant during the fourth quarter worth $25,000. Allworth Financial LP grew its position in shares of Ralliant by 134.4% during the 4th quarter. Allworth Financial LP now owns 511 shares of the company’s stock valued at $26,000 after buying an additional 293 shares during the last quarter. V Square Quantitative Management LLC acquired a new stake in Ralliant during the fourth quarter worth about $26,000. Manchester Capital Management LLC acquired a new stake in Ralliant during the second quarter worth about $29,000. Finally, Westfuller Advisors LLC bought a new position in Ralliant in the third quarter worth about $26,000.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.